EJAL® 40 – Advanced Bioremodeling with 40 mg Hyaluronic Acid
 
EJAL® 40 is a professional-grade biostimulant and bioremodeling injectable formulated with high molecular weight, non-cross-linked hyaluronic acid (40 mg/2 ml).
Developed by Medixa Srl (Italy), this innovative treatment restores skin structure, density, and elasticity by stimulating fibroblast activity, promoting the natural production of collagen and elastin.
It is designed to rejuvenate photoaged and sagging skin, improving firmness, tone, and hydration with visible, natural results.
 
Product Overview
EJAL® 40 acts deeply within the extracellular matrix (ECM), stimulating fibroblast renewal and reorganizing skin architecture.
Its bio-restructuring action provides progressive rejuvenation without altering facial volume — ideal for patients seeking a natural improvement in skin quality and radiance.
The treatment is performed using the 4-point biorevitalization technique, allowing uniform diffusion and minimizing downtime.
 
Technology & Composition
Technology: High Molecular Weight Non-Cross-Linked Hyaluronic Acid (HA)
Concentration: 40 mg / 2 ml (20 mg/ml)
Molecular Weight: 1,200–1,800 kDa (ideal for ECM remodeling)
Composition:
• Sodium Hyaluronate (40 mg)
• Sodium Chloride
• Dehydrated Monobasic Sodium Phosphate
• Dibasic Sodium Phosphate Dodecahydrate
• PPI Water (Purified Pyrogen-Free Water)
Form: Injectable solution, non-cross-linked HA
Packaging (Content):
• 1 prefilled syringe of 2 ml
• 2 sterile 30G needles
• Product labels and professional instructions
 
Indications & Treatment Areas
EJAL® 40 is indicated for the rejuvenation and bio-restructuring of the skin through deep hydration and dermal stimulation.
It effectively improves skin elasticity, firmness, and brightness while reducing signs of aging such as fine lines and wrinkles.
 
Recommended Treatment Areas:
Face (including nasolabial folds, marionette lines, forehead, and chin)
Neck
Décolletage
Glabellar region
Perioral and periorbital areas
 
Clinical Benefits
Stimulates Collagen & Elastin Production: Activates fibroblasts and strengthens the extracellular matrix.
Improves Firmness & Elasticity: Visibly enhances skin tone and texture.
Deep Hydration: Replenishes skin moisture for a healthy, luminous appearance.
Non-Volumizing, Natural Results: Does not alter facial expression or contours.
Minimally Invasive with No Downtime: Gentle procedure with biocompatible HA.
 
Treatment Protocol
Injection Technique: 4-Point Biorevitalization Method
Recommended Schedule:
• 3 sessions, spaced 2 weeks apart
• Maintenance: Repeat 2–3 times per year for sustained results
Depth of Injection: Superficial to mid-dermis
Procedure Time: 15–30 minutes
Post-Treatment: Avoid direct sun exposure or strong cosmetic treatments for 24–48 hours
 
Duration of Results
Results appear gradually, with visible improvement in skin tone, density, and radiance after the first session.
Effects typically last up to 6–9 months, depending on age, skin type, and lifestyle factors.
 
Manufacturer & Regulatory Information
Manufactured by Medixa Srl (Italy)
CE-marked Class III Medical Device under EU Regulation (MDR) 2017/745
ISO 13485 certified manufacturer
Distributed under compliance with AEMPS (Agencia Española de Medicamentos y Productos Sanitarios) in Spain and the European Union
 
For Professional Use Only:
As trusted distributors and providers of aesthetic medicine, Aesthisave® emphasizes that our products are intended strictly for professional use.
We insist that these treatments be administered only by licensed medical and healthcare professionals, ensuring the highest standards of safety, precision, and patient care.